Bd Phoenix Automated Microbiology System Trimethoprim - Gn 0.5-16 Ug/Ml
510(k) K030986
Active
Valid until
No expiry
FDA recalls
None foundDocuments
Trust
Unverified
Regulatory status
| Region | Authorization | Number | Date | Status |
|---|---|---|---|---|
| United States | FDA 510(k)SESE | NumberK030986 | Date16 May 2003 | StatusActive |
Recalls
No FDA recalls found in the data synced 6 Oct 2026.
Coverage
- Active
- Expiring
- Withdrawn
- Listed
- Not covered
United States — FDA 510(k) Active
Specification
- 510(k) Number
- FDA Product Code
- LON
- Device Class
- Class II
- Regulation
- 21 CFR Part 866.1645
- Advisory Committee
- Microbiology
- FDA Decision
- SESE Substantially Equivalent
Overview
AI-generated summary, 19 Sep 2026
The BD Phoenix Automated Microbiology System Trimethoprim – GN 0.5–16 µg/ml is an automated system for in vitro antimicrobial susceptibility testing (AST) of Gram-negative bacteria. It evaluates microbial growth and response to antimicrobial agents, including trimethoprim, to support clinical decision-making in microbiology laboratories. The system is designed to provide rapid and automated detection of bacterial susceptibility patterns, aiding in the selection of appropriate antimicrobial therapy.
This device is intended for use in clinical microbiology laboratories and is supplied as a reusable instrument with disposable consumables, including AST panels. The system operates under non-sterile conditions for the instrument itself, though consumables may require sterile handling as specified by the manufacturer. It is classified as FDA Class II and has received a Traditional 510(k) clearance for antimicrobial susceptibility testing. The trimethoprim concentration range of 0.5–16 µg/ml is included in the Gram-negative AST panels for testing bacterial isolates.
Other devices from Becton, Dickinson & Co.
Questions
AI-generated answers, 19 Sep 2026
What types of bacteria does this device test for susceptibility to trimethoprim, and how does it help in clinical decision-making?
This device tests Gram-negative bacteria for antimicrobial susceptibility to trimethoprim, with a concentration range of 0.5–16 µg/ml. It automates the detection of bacterial growth and response to antimicrobial agents, providing rapid results to help clinicians select the most effective antimicrobial therapy for infections caused by these bacteria.
Is the BD Phoenix Automated Microbiology System itself single-use, or are there disposable components that need to be replaced?
The BD Phoenix Automated Microbiology System is a reusable instrument, but it requires disposable consumables, specifically AST panels, for each use. These consumables may need sterile handling as directed by the manufacturer, though the instrument itself is not sterile.
What regulatory pathway was followed for this device’s clearance, and what class does it fall under?
This device received a Traditional 510(k) clearance from the FDA and is classified as a Class II medical device. The clearance was based on a determination of substantial equivalence to a predicate device, as indicated by the 'decision_code: SESE' and 'clearance_type: Traditional' in the submission.
How does the automated testing process differ from traditional manual methods, and what advantages does it offer?
Unlike traditional manual methods, the BD Phoenix Automated Microbiology System streamlines antimicrobial susceptibility testing (AST) by automating microbial growth detection and response evaluation. This reduces human error, speeds up results, and allows for consistent, rapid analysis of bacterial susceptibility to trimethoprim and other agents, improving efficiency in clinical microbiology labs.